Getinge has acquired Pennamed, a UK specialist distributor of endoscopic consumables to NHS trusts and private healthcare providers. The transaction was reported on 5 November 2026. The purchase price was not disclosed in the sources.
Pennamed was founded in 2007. According to the source, it had developed an established nationwide presence in endoscopy and decontamination, alongside strong customer relationships. Getinge, described in the source as a global medtech company with annual revenues measured in billions, already had expertise in endoscope reprocessing, infection control and washer-disinfector technology.
The source states that combining the two businesses allows them to offer hospitals a more integrated solution rather than approaching customers with separate products and services.
Grant Thornton, which advised Pennamed's shareholders, described the sale process as highly competitive, with interest from both strategic buyers and private equity, according to the source.
The source's assessment is that a medical device distributor does not necessarily need to manufacture anything to be strategically valuable, and that relationships, technical knowledge, a specialist product portfolio and the ability to serve healthcare customers can all be important commercial assets. It adds that the acquisition illustrates why established, specialist UK medtech businesses attract buyer attention.